New Forte Kose ex Tablet
Natural health product licensed in Canada
- Other names
- Gai Gu Gu Aqua- Kalzium Tablet, New FORTE KNOCHEN TABLETS, New chelacalmate Tablets, Sin pu Complex Kalcium Tablet, Super Potente calcareous Tablet
- Licence holder
- Ren YI international co., Ltd
- NPN or DIN-HM
- 80128109
- Status
- Active licence
- Licence date
- 17 November 2023
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 20 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Cuivre: up to 3,500 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2,000 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc | 20 mg | 20,000 µg |
| Magnésium Source : Oxyde de magnésium | 100 mg | 100,000 µg |
| Calcium Source : Chélate d'acide aminé de calcium | 480 mg | 480,000 µg |
| Calcium Source : Produit de chélation de calcium et de protéine végétale hydrolysée (PVH) | 180 mg | 180,000 µg |
| Cuivre Source : Produit de chélation de cuivre (II) et de protéine végétale hydrolysée (PVH) | 3.5 mg | 3,500 µg |
| Manganèse Source : Produit de chélation de manganèse (II) et de protéine végétale hydrolysée (PVH) | 2.5 mg | 2,500 µg |
| Vitamine D Source : Cholécalciférol | 5 mcg | 5 µg |
| Vitamine K2 Source : Ménaquinones | 30 mcg | 30 µg |
| Vitamine K2 Source : Ménatétrénone | 30 mcg | 30 µg |
Non-medicinal ingredients
Glycolate d'amidon sodique, Cellulose microcristalline, Hydroxypropyl méthylcellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in energy metabolism/(and) tissue formation. Helps in the development and maintenance of bones/(and) teeth. Helps in the maintenance of bones. Helps to form red blood cells. Helps to maintain/support healthy bones/hair/nail/(and) skin. Helps to maintain/support healthy skin. Helps to maintain/support immune function/the immune system. Helps to maintain/support normal iron transport in the body. Helps to maintain/support normal muscle function. Helps to maintain/support the body's ability to metabolize nutrients. Source of/Provides (an) electrolyte(s) for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80128109
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.